Estimate Recalculated Nov 7, 2024 05:16PM EST
Gina Mazzariello does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Amylyx Pharmaceuticals, Inc..
Gina Mazzariello's CIK is 0001913765
2024 was Gina Mazzariello's most active year for acquiring shares with 4 total transactions. Gina Mazzariello's most active month to acquire stocks was the month of January. 2023 was Gina Mazzariello's most active year for disposing of shares, totalling 3 transactions. Gina Mazzariello's most active month to dispose stocks was the month of January. 2022 saw Gina Mazzariello paying a total of $0.00 for 223,000 shares, this is the most they've acquired in one year. In 2023 Gina Mazzariello cashed out on 10,250 shares for a total of $252,358.26, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Form 4 | -6.46% | -10.46K | $1.88 | -$19.65K | May 16, 2024 | 151.48K | Sale | — | May 15 |
Form 4 | 234.18% | 190.56K | — | — | Apr 18, 2024 | 271.93K | Grant | — | Apr 16 |
Form 4 | -1.86% | -1.54K | $18.73 | -$28.84K | Mar 07, 2024 | 81.37K | Sale | — | Mar 05 |
Form 4 | 198.22% | 91.67K | — | — | Feb 28, 2024 | 137.91K | Grant | — | Feb 26 |
Form 4 | -5.78% | -2.84K | $18.76 | -$53.23K | Feb 27, 2024 | 46.25K | Sale | — | Feb 23 |
Form 4 | -11.16% | -6.16K | $20.88 | -$128.69K | Aug 17, 2023 | 49.08K | Sale | — | Aug 15 |
Form 4 | -0.90% | -500.00 | — | — | May 19, 2023 | 55.25K | Grant | — | May 17 |
Form 4 | 269.51% | 100.83K | — | — | Mar 20, 2023 | 138.25K | Grant | — | Mar 16 |
Form 4 | -8.75% | -3.59K | $34.49 | -$123.67K | Feb 28, 2023 | 37.41K | Sale | Scheduled | Feb 24 |
Form 4 | — | 223.00K | — | — | Feb 28, 2022 | 223.00K | Grant | — | Feb 22 |
Form 3 | — | — | — | — | Feb 28, 2022 | — | — | — | — |